277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill with imprint 277 is Brown, Round and has been identified as Januvia 100 mg. It is supplied by Merck & Company Inc..
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 277
Januvia
- Generic Name
- sitagliptin
- Imprint
- 277
- Strength
- 100 mg
- Color
- Brown
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00006-0277 | Merck |
| 54569-5925 | A-S Medication Solutions, LLC (repackager) |
| 54868-5840 | Physicians Total Care Inc. (repackager) |
| 35356-0103 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "277"
More about Januvia (sitagliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 109 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
